Where is Temple headquartered?

Temple is headquartered in Gurugram, India. The company has a team of 30+ people.

Temple operates in the AI in Healthcare sector. An experimental wearable sensor device that continuously monitors cerebral blood flow in real-time, designed to measure physiological and neurological metrics that existing wearables cannot track with comparable precision. Provides first-of-its-kind continuous, real-time brain blood flow monitoring using proxy measurements via a non-invasive temple-mounted sensor, enabling insights into cognitive performance, mental load management, and brain health that no existing wearable can deliver.

When was Temple founded?

Temple was founded in 2024. It is based in Gurugram, India.

Who is the CEO of Temple?

Deepinder Goyal is the CEO of Temple. The company was founded in 2024.

Where is Temple located?

Temple is headquartered in Gurugram, India.

What funding stage is Temple at?

Temple is currently at the Seed stage.

How many employees does Temple have?

Temple has approximately 30+ employees.

Temple

Category: AI in Healthcare

An experimental wearable sensor device that continuously monitors cerebral blood flow in real-time, designed to measure physiological and neurological metrics that existing wearables cannot track with comparable precision. Temple was founded in 2024. The company is led by Deepinder Goyal. Based in Gurugram, India. Team size: 30+. Total funding raised: $54.0M. Latest round: Seed Round. Key investors include ["Steadview Capital","Peak XV Partners","NK Squared (Nikhil & Nithin Kamath)","Deepinder Goyal (Founder)","Dharana Capital","InfoEdge Ventures"].

Founded: 2024
Headquarters: Gurugram, India
Team size: 30+
Total funding: $54.0M

Value proposition

Provides first-of-its-kind continuous, real-time brain blood flow monitoring using proxy measurements via a non-invasive temple-mounted sensor, enabling insights into cognitive performance, mental load management, and brain health that no existing wearable can deliver.

Products and solutions

["Temple Wearable Sensor (temple-mounted patch device)","Real-time Cerebral Blood Flow Monitoring System","Brain Health & Cognitive Performance Analytics Platform"]

Unique value

First wearable device to continuously and non-invasively monitor cerebral blood flow in real-time through a small sensor patch worn on the temple region. Based on proprietary 'Gravity Aging Hypothesis' - a novel theory suggesting gravity gradually reduces blood flow to the brain over a lifetime, potentially accelerating aging. Uniquely requires engineers who are also athletes with specific body fat requirements (<16% for men, <26% for women).

Target customer

Elite performance athletes (primary target), with potential future applications for students tracking focus and fatigue, older adults monitoring cognitive decline, and health-conscious individuals

Industries served

["Healthcare AI","Wearable Technology","Sports Technology & Performance Analytics","Neuroscience & Brain Health","Health-tech"]

Technology advantage

Combines Near-Infrared Spectroscopy (NIRS) technology to estimate brain oxygenation as a proxy for cerebral blood flow, embedded AI for pattern recognition, computer vision, high-precision sensors, and brain-computer interface research. The device uses proxy measurements to monitor brain flow continuously without invasive procedures, filling a gap left by existing wearables that cannot measure these neurological metrics with comparable precision.

How they differentiate

First wearable device to continuously monitor cerebral blood flow in real-time through proxy measurements using Near-Infrared Spectroscopy (NIRS) technology. Based on proprietary 'Gravity Aging Hypothesis' - a novel theory suggesting gravity gradually reduces blood flow to the brain over a lifetime. Unlike competitors that track general fitness metrics, Temple focuses exclusively on brain health and cognitive performance monitoring with unprecedented precision. Uniquely requires engineers who are also athletes with specific body fat requirements (<16% men, <26% women).

Main competitors

["WHOOP","Oura Ring","Ultrahuman"]

Key partnerships

["Steadview Capital (Lead Investor)","Peak XV Partners (Lead Investor)","NK Squared (Nikhil and Nithin Kamath)","Continue Research (Longevity research venture - founded by Deepinder Goyal)","Former Zomato investors","30+ Temple employees (participated in funding round at par valuation)"]

Notable customers

[]

Major milestones

["Raised $54M seed funding at $190M valuation (Feb 2026)","Deepinder Goyal invested ₹104 crore personally in seed round","30+ employees participated in funding at full valuation","Founder stepped down as Zomato Group CEO (Feb 2026) to focus on Temple","Device prototype spotted on founder during podcast, generating viral attention","Waitlist announced for public access (Feb 2026)"]

Growth metrics

Pre-revenue experimental prototype stage with $190M post-money valuation. 30+ team members participated in funding round at par valuation. Founder committed $25M personal capital to related longevity research venture (Continue Research).

Market positioning

Premium, experimental health-tech wearable positioned as 'the ultimate wearable for elite performance athletes' rather than general consumers. Pre-revenue prototype stage targeting specialized athletic performance and brain health optimization. Occupies unique niche between medical devices and consumer wearables.

Geographic focus

Headquartered in Gurugram, India with global athlete reach. Strong backing from India-based investors (Steadview Capital, Peak XV Partners) with deep connections to Zomato ecosystem. Founded by prominent Indian entrepreneur with international expansion potential.

Patents and IP

No registered patents disclosed publicly as of latest update

About Deepinder Goyal

Founder & CEO of Zomato (2008-Feb 2026); Vice Chairman of Eternal (Feb 2026-present); Founder of Temple (2024-present), Continue Research (2024-present), and LAT Aerospace; Management Consultant at Bain & Company (2005-2007)

Official website: https://app.temple.health